Follow this preprint
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2
View ORCID ProfileEric J. Nilles, Elizabeth W. Karlson, Maia Norman, Tal Gilboa, Stephanie Fischinger, Caroline Atyeo, View ORCID ProfileGuohai Zhou, Christopher L. Bennett, Nicole V. Tolan, Karina Oganezova, View ORCID ProfileDavid R. Walt, Galit Alter, Daimon P. Simmons, Peter Schur, Petr Jarolim, Lindsey R. Baden
doi: https://doi.org/10.1101/2020.06.24.20139006
Now published in The Journal of Applied Laboratory Medicine doi: 10.1093/jalm/jfab072
Eric J. Nilles
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
Elizabeth W. Karlson
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
Maia Norman
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
3Tufts University School of Medicine, Boston, MA
4Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA
Tal Gilboa
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
4Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA
Stephanie Fischinger
5Ragon Institute of MGH, MIT and Harvard, Cambridge, MA
Caroline Atyeo
5Ragon Institute of MGH, MIT and Harvard, Cambridge, MA
Guohai Zhou
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
Christopher L. Bennett
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
6Massachusetts General Hospital, Boston, MA
Nicole V. Tolan
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
Karina Oganezova
1Brigham and Women’s Hospital, Boston, MA
David R. Walt
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
4Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, MA
Galit Alter
2Harvard Medical School, Boston, MA
5Ragon Institute of MGH, MIT and Harvard, Cambridge, MA
7Harvard T.H. Chan School of Public Health
Daimon P. Simmons
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
Peter Schur
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
Petr Jarolim
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA
Lindsey R. Baden
1Brigham and Women’s Hospital, Boston, MA
2Harvard Medical School, Boston, MA

Posted June 26, 2020.
Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2
Eric J. Nilles, Elizabeth W. Karlson, Maia Norman, Tal Gilboa, Stephanie Fischinger, Caroline Atyeo, Guohai Zhou, Christopher L. Bennett, Nicole V. Tolan, Karina Oganezova, David R. Walt, Galit Alter, Daimon P. Simmons, Peter Schur, Petr Jarolim, Lindsey R. Baden
medRxiv 2020.06.24.20139006; doi: https://doi.org/10.1101/2020.06.24.20139006
Now published in The Journal of Applied Laboratory Medicine doi: 10.1093/jalm/jfab072
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (413)
- Allergy and Immunology (734)
- Anesthesia (215)
- Cardiovascular Medicine (3142)
- Dermatology (267)
- Emergency Medicine (467)
- Epidemiology (13106)
- Forensic Medicine (15)
- Gastroenterology (873)
- Genetic and Genomic Medicine (4923)
- Geriatric Medicine (453)
- Health Economics (758)
- Health Informatics (3104)
- Health Policy (1110)
- Hematology (414)
- HIV/AIDS (978)
- Medical Education (459)
- Medical Ethics (121)
- Nephrology (507)
- Neurology (4684)
- Nursing (248)
- Nutrition (692)
- Oncology (2414)
- Ophthalmology (688)
- Orthopedics (270)
- Otolaryngology (334)
- Pain Medicine (313)
- Palliative Medicine (88)
- Pathology (522)
- Pediatrics (1254)
- Primary Care Research (526)
- Public and Global Health (7244)
- Radiology and Imaging (1619)
- Respiratory Medicine (949)
- Rheumatology (463)
- Sports Medicine (407)
- Surgery (522)
- Toxicology (65)
- Transplantation (223)
- Urology (193)